ASSENT 3: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 June 2009

  • curprev 15:0015:00, 29 June 2009‎ Michaelagibson talk contribs‎ 259 bytes +259‎ ←Redirected page to [[The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Ran
Retrieved from "https://www.wikidoc.org/index.php/ASSENT_3"